Growing community of inventors

San Francisco, CA, United States of America

Michael Tsang

Average Co-Inventor Count = 13.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 19

Michael TsangRobert F Halenbeck (4 patents)Michael TsangKirk William Johnson (4 patents)Michael TsangBao-lu Chen (4 patents)Michael TsangGlenn J Dorin (4 patents)Michael TsangGary V Johnson (4 patents)Michael TsangHassan Madani (4 patents)Michael TsangMark E Gustafson (4 patents)Michael TsangBo H Arve (4 patents)Michael TsangGregory L Pattison (4 patents)Michael TsangGary S Bild (4 patents)Michael TsangManinder S Hora (2 patents)Michael TsangRajsharan K Rana (2 patents)Michael TsangManinder S Hoba (2 patents)Michael TsangRaisharan K Rana (1 patent)Michael TsangRejsharan K Bana (1 patent)Michael TsangMichael Tsang (4 patents)Robert F HalenbeckRobert F Halenbeck (40 patents)Kirk William JohnsonKirk William Johnson (36 patents)Bao-lu ChenBao-lu Chen (18 patents)Glenn J DorinGlenn J Dorin (18 patents)Gary V JohnsonGary V Johnson (8 patents)Hassan MadaniHassan Madani (5 patents)Mark E GustafsonMark E Gustafson (5 patents)Bo H ArveBo H Arve (4 patents)Gregory L PattisonGregory L Pattison (4 patents)Gary S BildGary S Bild (4 patents)Maninder S HoraManinder S Hora (24 patents)Rajsharan K RanaRajsharan K Rana (3 patents)Maninder S HobaManinder S Hoba (2 patents)Raisharan K RanaRaisharan K Rana (1 patent)Rejsharan K BanaRejsharan K Bana (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (2 from 832,680 patents)

2. G.d. Searle LLC (2 from 33 patents)

3. Chiron Corporation (1 from 656 patents)

4. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)


4 patents:

1. 7226757 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor

2. 7022672 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor

3. 6323326 - Method of solubilizing, purifying, and refolding protein

4. 6319896 - Method of solubilizing, purifying, and refolding protein

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…